HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,763 | -54.8% | 15,465 | -54.8% | 0.07% | -70.8% |
| Q1 2023 | $1,305,831 | +69.7% | 34,193 | +152.9% | 0.24% | +32.1% |
| Q4 2022 | $769,288 | -6.1% | 13,520 | -34.8% | 0.18% | -1.1% |
| Q3 2022 | $819,000 | +13.9% | 20,724 | +26.8% | 0.19% | -3.6% |
| Q2 2022 | $719,000 | +59.8% | 16,342 | +47.7% | 0.19% | +31.3% |
| Q3 2021 | $450,000 | +86.0% | 11,065 | +90.3% | 0.15% | -1.3% |
| Q1 2021 | $242,000 | +13.1% | 5,815 | +16.0% | 0.15% | +13.7% |
| Q4 2020 | $214,000 | -29.4% | 5,015 | -56.4% | 0.13% | -42.0% |
| Q3 2020 | $303,000 | -24.1% | 11,515 | -22.6% | 0.23% | -55.2% |
| Q2 2020 | $399,000 | -80.2% | 14,884 | -86.9% | 0.50% | -18.4% |
| Q4 2019 | $2,020,000 | +503.0% | 113,958 | +170.3% | 0.62% | +852.3% |
| Q2 2013 | $335,000 | – | 42,166 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |